HIV

A new interdisciplinary research institute in South Africa to fight tuberculosis (TB), HIV and related diseases has been announced on Tuesday, following a merger between two leading research institutions, with UCL as a key academic partner

Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.

GlaxoSmithKline (GSK) and Pfizer are spinning out all HIV/AIDS-related R&D and marketed drugs into a separate, jointly-controlled company.